Athira Pharma settlements

Athira Pharma was the subject of a securities class action settlement — formally titled Athira Pharma Securities Litigation — for investors who purchased or acquired the company's publicly traded common stock between September 17, 2020, and June 17, 2021. The total settlement fund was $10,000,000 in cash, available to class members who filed verified claims. The claim deadline of September 6, 2024, has passed; this verified record is maintained for reference.

Check what you may be owed Free · takes 20 seconds

Published directory

1 published record

Proof required

False Advertising

Athira

Athira Pharma, a biotech developing an Alzheimer's treatment, was sued after allegations surfaced about manipulated research images used to support the company's science, and investors said the news drove the stock down. The case settled for a $10,000,000 cash fund covering stock bought between September 17, 2020 and June 17, 2021. The claim deadline passed in September 2024, and the case is now closed.

Claim window closed Evidence-verified

Related companies with published settlements

Share this collection — free to repost with a link back.

There may be money with your name on it.

Free to browse and track. Every record shows its official-evidence status — and you open the official claim form yourself.

Check what you may be owed Browse all settlements